JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257548

Human MYSM1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

MYSM1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon8 and 2 bp insertion in exon8.

View Alternative Names

2A-DUB, Histone H2A deubiquitinase, Histone H2A deubiquitinase MYSM1, KIAA1915, MYSM1 Myb-like, SWIRM and MPN domains 1, MYSM1_HUMAN, Myb like, SWIRM and MPN domain containing protein, Myb-like, Myb-like, SWIRM and MPN domains 1, RP4-592A1.1, SWIRM and MPN domain-containing protein 1

3 Images
Western blot - Human MYSM1 knockout HEK-293T cell lysate (AB257548)
  • WB

Lab

Western blot - Human MYSM1 knockout HEK-293T cell lysate (AB257548)

Lane 1 : Wild-type HEK-293T cell lysate 20 μg
Lane 2 : MYSM1 knockout HEK-293T cell lysate 20 μg
Lane 3 : HeLa cell lysate 20 μg
Lane 4 : RT-4 cell lysate 20 μg
False colour image of Western blot : Anti-MYSM1 antibody [EPR18657] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab193081 was shown to bind specifically to MYSM1. A band was observed at 110 kDa in wild-type HEK-293T cell lysates with no signal observed at this size in MYSM1 knockout cell line ab267297 (knockout cell lysate ab257548). To generate this image, wild-type and MYSM1 knockout HEK-293T cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-MYSM1 antibody [EPR18657] (<a href='/en-us/products/primary-antibodies/mysm1-antibody-epr18657-ab193081'>ab193081</a>) at 1/1000 dilution

Lane 1:

Wild-type HEK-293T cell lysate at 20 µg

Lane 2:

MYSM1 knockout HEK-293T cell lysate at 20 µg

Lane 2:

Western blot - Human MYSM1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-mysm1-knockout-hek-293t-cell-line-ab267297'>ab267297</a>)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

RT-4 cell lysate at 20 µg

Predicted band size: 95 kDa

Observed band size: 110 kDa

false

Sanger Sequencing - Human MYSM1 knockout HEK-293T cell lysate (AB257548)
  • Sanger seq

Unknown

Sanger Sequencing - Human MYSM1 knockout HEK-293T cell lysate (AB257548)

Allele-2 : 2 bp insertion in exon8

Sanger Sequencing - Human MYSM1 knockout HEK-293T cell lysate (AB257548)
  • Sanger seq

Unknown

Sanger Sequencing - Human MYSM1 knockout HEK-293T cell lysate (AB257548)

Allele-1 : 1 bp insertion in exon8

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon8 and 2 bp insertion in exon8.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257548-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human MYSM1 knockout HEK293T cell lysate", "number":"AB257548-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB257548-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
MYSM1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MYSM1 also known as Myb-like SWIRM and MPN domains 1 functions as a histone H2A deubiquitinase. This protein weighs approximately 83 kDa. MYSM1 is found in the nucleus and shows expression in various tissues including hematopoietic cells such as T cells and bone marrow. By removing ubiquitin from histone H2A MYSM1 influences chromatin structure and gene transcription.
Biological function summary

MYSM1 plays an important role in regulating gene expression during processes like hematopoiesis and immune development. It forms part of a chromatin remodeling complex that modulates transcriptional activity by altering nucleosome configuration. This function is essential for proper stem cell maintenance and differentiation by ensuring that transcriptionally active and inactive regions are appropriately maintained and accessed.

Pathways

MYSM1 participates in the ubiquitin-proteasome pathway and is involved in DNA damage response. It associates closely with proteins like TP53 where it aids in governing cell cycle progression and apoptosis. MYSM1 also interacts with histone modification machinery exerting effects on transcriptional silencing and activation particularly influencing genes associated with immune cell lineage commitment.

MYSM1 impacts conditions such as bone marrow failure and immunodeficiency. It connects with the TP53 protein where mutations or dysregulation in this pathway can lead to hematological abnormalities and impaired immune function. MYSM1 deficiency has been implicated in defective T cell maturation and aberrant myeloid lineage decisions contributing to these disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com